RIVANNA Reaches 100 Patents for AI Ultrasound Platform
Charlottesville, Virginia, September 22, 2026 RIVANNA, a medical technology company developing AI-enabled clinical decision-support solutions, has reached a significant...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Charlottesville, Virginia, September 22, 2026 RIVANNA, a medical technology company developing AI-enabled clinical decision-support solutions, has reached a significant...
Covington, Kentucky, September 22, 2026 Gravity Diagnostics, a CAP-accredited and CLIA-certified laboratory, has been named the exclusive laboratory partner...
London, United Kingdom, September 22, 2026 Smith+Nephew has announced U.S. FDA 510(k) clearance for its LANDMARKâ„¢ Total Knee System...
